ITs not serious.Runs are on the board.AEI did serious DD on ANP..They came on board for DMD..
To get a bonus with an IND for RRMS and SPMS a market worth $20 billion.
Do you know how difficult it is to get a INd approved by the FDA.especially with a New Drug in Antisense and a journey to the primary target through the CNS..?
KP your own words "This company is on its knees and with nobody wanting to license out its unproven compounds, its in a very dire situation ."
Now...that the FDA has approved the IND it will generate more PHARMA interest.No one thought it was possible except the ANP board.
Ann: ATL1102 for MS and DMD Update, page-26
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.8¢ |
Change
-0.004(4.35%) |
Mkt cap ! $79.33M | |||
| Open | High | Low | Value | Volume |
| 9.1¢ | 9.2¢ | 8.7¢ | $87.86K | 983.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 61583 | 8.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.8¢ | 16883 | 1 |
View Market Depth
| Last trade - 15.58pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
8.8¢ |
Change
-0.004 ( 2.76 %) |
||||
| Open | High | Low | Volume | ||
| 9.1¢ | 9.1¢ | 8.7¢ | 237651 | ||
| Last updated 15.58pm 17/06/2024 ? | |||||
| PER (ASX) Chart |
